Trump-touted malaria drug fails in Covid-19 study
Published:
2020-05-09 04:37:59 BdST
Update:
2024-05-16 21:02:41 BdST
Live Desk: A malaria drug that was touted by US President Donald Trump and widely used as a potential treatment for patients with Covid-19 failed to help those with infections stay off ventilators or live longer, according to a study published in the New England Journal of Medicine.
Researchers at New York-Presbyterian Hospital and Columbia University Irving Medical Center in New York City evaluated 1,376 consecutive patients who showed up at the emergency room with symptoms of coronavirus, comparing the fate of those who received the medication, hydroxychloroquine, to those who didn’t.
Nearly 60% of the patients were given the drug, typically within 48 hours, and they were more sick on average.
There were no significant differences between the groups in the number of patients who needed to be put on a ventilator or who died, even after taking into account the differences between them, the researchers said.
Dhaka, 08 May (campuslive24.com)//Ait
Topic:
Share Your Valuable Comments: